Debt-to-equity in % of NAVIDEA BIOPHARMACEUTICALS, INC. from Q1 2012 to Q3 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
NAVIDEA BIOPHARMACEUTICALS, INC. quarterly Debt-to-equity history and change rate from Q1 2012 to Q3 2023.
  • NAVIDEA BIOPHARMACEUTICALS, INC. Debt-to-equity for the quarter ending 30 Sep 2023 was -186 %, a 24% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

NAVIDEA BIOPHARMACEUTICALS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2023 -186 +58.9 +24% 30 Sep 2023
Q2 2023 -182 +458 +71.5% 30 Jun 2023
Q1 2023 -152 -476 -147% 31 Mar 2023
Q4 2022 -177 -333 -213% 31 Dec 2022
Q3 2022 -245 -384 -276% 30 Sep 2022
Q2 2022 -640 -821 -454% 30 Jun 2022
Q1 2022 324 -296 -47.7% 31 Mar 2022
Q4 2021 156 +961 31 Dec 2021
Q3 2021 139 +512 30 Sep 2021
Q2 2021 181 +498 30 Jun 2021
Q1 2021 621 +1.69K 31 Mar 2021
Q4 2020 -805 +2.12K +72.5% 31 Dec 2020
Q3 2020 -373 -1.11K -151% 30 Sep 2020
Q2 2020 -317 -774 -170% 30 Jun 2020
Q1 2020 -1.07K -1.56K -320% 31 Mar 2020
Q4 2019 -2.93K -3.25K -995% 31 Dec 2019
Q3 2019 734 +550 +299% 30 Sep 2019
Q2 2019 456 +352 +337% 30 Jun 2019
Q1 2019 487 +409 +523% 31 Mar 2019
Q4 2018 327 +274 +518% 31 Dec 2018
Q3 2018 184 +918 30 Sep 2018
Q2 2018 104 +290 30 Jun 2018
Q1 2018 78.1 +214 31 Mar 2018
Q4 2017 52.9 +170 31 Dec 2017
Q3 2017 -734 -615 -518% 30 Sep 2017
Q2 2017 -185 -62.8 -51.2% 30 Jun 2017
Q1 2017 -136 -5.01 -3.82% 31 Mar 2017
Q4 2016 -117 +17.2 +12.8% 31 Dec 2016
Q3 2016 -119 +18.6 +13.5% 30 Sep 2016
Q2 2016 -123 +20.9 +14.5% 30 Jun 2016
Q1 2016 -131 +21.5 +14.1% 31 Mar 2016
Q4 2015 -134 +52.2 +28% 31 Dec 2015
Q3 2015 -137 +117 +46.1% 30 Sep 2015
Q2 2015 -143 +393 +73.3% 30 Jun 2015
Q1 2015 -153 +1.28K +89.3% 31 Mar 2015
Q4 2014 -186 -44.9K -100% 31 Dec 2014
Q3 2014 -255 -3.83K -107% 30 Sep 2014
Q2 2014 -536 +1.76K +76.6% 30 Jun 2014
Q1 2014 -1.43K -2.02K -342% 31 Mar 2014
Q4 2013 44.7K +44.6K +26121% 31 Dec 2013
Q3 2013 3.57K +3.49K +4123% 30 Sep 2013
Q2 2013 -2.29K -2.34K -4959% 30 Jun 2013
Q1 2013 592 +548 +1249% 31 Mar 2013
Q4 2012 171 31 Dec 2012
Q3 2012 84.5 30 Sep 2012
Q2 2012 47.2 30 Jun 2012
Q1 2012 43.9 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.